Washington, DC -- SNR Denton announced today Sally P. Teng, Ph.D., has joined the firm as a senior managing associate in its Intellectual Property and Technology practice. Dr. Teng comes from Milbank, Tweed, Hadley, & McCloy and will reside in SNR Denton’s Washington, DC, office.
Dr. Teng has extensive experience in various aspects of patent law in the biotechnological, pharmaceutical and chemical areas, including counseling, preparation and prosecution of domestic and international patent applications, patent validity analyses, due diligence analyses, freedom-to-operate analyses, and handling reexamination proceedings before the United States Patent and Trademark Office (USPTO) and opposition proceedings before international patent offices. Her practice also includes patent litigation, where she will work closely with SNR Denton’s patent litigation team in handling a wide variety of patent disputes. Among other things, Dr. Teng has provided technical analysis and discovery support, and has been involved in work with expert witnesses, analysis of validity and infringement issues, and motion practice.
Prior to private practice, Dr. Teng served as a patent examiner for seven years in the biotechnology group of the USPTO, where she examined patent applications in the field of cytokines, growth factors and receptors. In 1999, she received the Department of Commerce Bronze Medal Award for superior federal service.
"We are thrilled to have Sally on board. She has strong experience in IP protection of biotechnology and pharmaceutical inventions and builds on the already extensive bench of biotech Ph.D.s in our Intellectual Property group," said Dr. Robert Hanson, head of SNR Denton’s Intellectual Property and Technology practice and Health and Life Sciences sector team.
“Sally is a highly-experienced and well-respected scientist and patent lawyer who brings additional biotechnological, pharmaceutical and chemical skills and experience to our patent prosecution and patent litigation practices and our clients around the globe,” said Martin Bruehs, head of SNR Denton’s chemical patent practice.
Dr. Teng received her B.A. in chemistry from Wellesley College and a Ph.D. in chemistry from Yale University. She conducted her doctoral research in biophysical chemistry investigating the photochemistry of DNA and drug-DNA interaction. Following graduation from Yale, she worked as a postdoctoral fellow at the Massachusetts General Hospital and Harvard Medical School in molecular neurobiology characterizing Growth Associated Protein 43 (GAP-43) binding proteins. Dr. Teng received her J.D. from George Mason University School of Law. She is fluent in Mandarin Chinese.
About SNR Denton
SNR Denton is a client-focused international legal practice delivering quality and value. We serve clients in key business and financial centers from more than 60 locations worldwide, through offices, associate firms and special alliances across the US, the UK, Europe, the Middle East, Russia and the CIS, Asia Pacific and Africa, making us a top 25 legal services provider by lawyers and professionals. Joining the complementary top tier practices of its founding firms—Sonnenschein Nath & Rosenthal LLP and Denton Wilde Sapte LLP—SNR Denton offers business, government and institutional clients premier service and a disciplined focus to meet evolving needs in eight key industry sectors: Energy, Transport and Infrastructure; Financial Institutions and Funds; Government; Health and Life Sciences; Insurance; Manufacturing; Real Estate, Retail and Hotels; and Technology, Media and Telecommunications. Please see snrdenton.com for more information and Legal Notices.